Basics Relay Therapeutics, Inc. IPO Date: July 16, 2020 Sector: Healthcare Industry: Biotech Market Cap: $488.62M Activated in VL: True Average Daily Range Avg Daily Range: $0.68 | 3.40% Avg Daily Range (30 D): $0.11 | 3.84% Avg Daily Range (90 D): $0.14 | 4.24% Institutional Daily Volume Avg Daily Volume: .92M Avg Daily Volume (30 D): 1.89M Avg Daily Volume (90 D): 1.93M Trade Size Avg Trade Size (Sh.): 89 Avg Trade Size (Sh.) (30 D): 163 Avg Trade Size (Sh.) (90 D): 146 Institutional Trades Total Inst.Trades: 2,312 Avg Inst. Trade: $2.28M Avg Inst. Trade (30 D): $.86M Avg Inst. Trade (90 D): $1.1M Avg Inst. Trade Volume: .15M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.9M Avg Closing Trade (30 D): $.74M Avg Closing Trade (90 D): $.98M Avg Closing Volume: 190.59K         News May 27, 2025 @ 1:45 PM Healthcare's Quiet AI Boom Is Creating a New Class... Source: Prnewswire Dec 11, 2024 @ 11:00 AM Relay Therapeutics Announces Updated Interim Data ... Source: N/A Sep 11, 2024 @ 10:46 PM Why Relay Therapeutics Plummeted by Nearly 14% Tod... Source: Eric Volkman Sep 11, 2024 @ 12:21 AM Relay Therapeutics Announces Pricing of Public Off... Source: N/A Jul 17, 2024 @ 12:01 PM Expert Ratings For Relay Therapeutics - Benzinga Source: Benzinga Insights, Benzinga Staff Writer Financials   TTM Q1 2025 Q4 2024 Basic EPS $-2.2 $-.46 $-.42 Diluted EPS $-2.2 $-.46 $-.42 Revenue $ 7.68M $ 7.68M $ M Gross Profit $ $ $ Net Income / Loss $ -333.39M $ -77.07M $ -76M Operating Income / Loss $ -366.97M $ -84.87M $ -84.98M Cost of Revenue $ $ $ Net Cash Flow $ -29.17M $ M $ -28.07M PE Ratio